Amylyx prices newly approved ALS drug at $158,000 per year
Published by Reuters By Leroy Leo (Reuters) -Amylyx Pharmaceuticals Inc on Friday set the list price of its newly approved drug to treat amyotrophic lateral sclerosis (ALS) at about $158,000 per year in the United States, …Read More »
Two thirds of U.S. adults don’t plan on getting COVID boosters soon – poll
Published by Reuters By Michael Erman NEW YORK (Reuters) – Around two-thirds of adults in the United States do not plan to get updated COVID-19 booster shots soon, according to a survey conducted by the Kaiser …Read More »
Comedian Trevor Noah to leave ‘The Daily Show’ after seven years
Published by Reuters By Kanishka Singh WASHINGTON (Reuters) -Comedian Trevor Noah, host of “The Daily Show” on Comedy Central, said he was going to leave the program after hosting it for seven years, indicating he wanted …Read More »
2020 election conspiracists could soon oversee voting in U.S. battleground states
Published by Reuters By Andrew R.C. Marshall, Joseph Tanfani and Peter Eisler (Reuters) – Two far-right U.S. politicians who want to upend the way votes are cast and counted are tied or leading in races to …Read More »